Get the Stockscreener App
0.0751
20.86%
-0.0198
Pre-market:
.07
-0.0051
-6.79%
Tnf Pharmaceuticals Inc stock is traded at $0.0751, with a volume of 77.61M.
It is down -20.86% in the last 24 hours and down -41.96% over the past month.
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms, Isomyosamine and Supera-CBD. Isomyosamine is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B. The company has one reportable segment focused on Isomyosamine.
See More
Previous Close:
$0.0949
Open:
$0.0897
24h Volume:
77.61M
Relative Volume:
2.35
Market Cap:
$1.07M
Revenue:
-
Net Income/Loss:
$-23.66M
P/E Ratio:
-0.00543
EPS:
-13.84
Net Cash Flow:
$-10.14M
1W Performance:
-26.59%
1M Performance:
-41.96%
6M Performance:
-84.32%
1Y Performance:
-95.80%
1-Day Range:
$0.0664
$0.0929
1-Week Range:
$0.0664
$0.1078
52-Week Range:
$0.0664
$2.16
Tnf Pharmaceuticals Inc Stock (TNFA) Company Profile
Name
Tnf Pharmaceuticals Inc
Sector
Industry
Phone
856-848-8698
Address
1185 AVENUE OF THE AMERICAS, NEW YORK
Compare TNFA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNFA
Tnf Pharmaceuticals Inc
|
0.0751 | 1.44M | 0 | -23.66M | -10.14M | -13.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.46 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.16 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.55 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.73 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.97 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tnf Pharmaceuticals Inc Stock (TNFA) Latest News
What’s the recovery path for long term holders of TNF Pharmaceuticals Inc.July 2025 Setups & AI Forecast Swing Trade Picks - Newser
Using Ichimoku Cloud for TNF Pharmaceuticals Inc. technicalsTrade Entry Summary & Free Daily Entry Point Trade Alerts - Newser
Will TNF Pharmaceuticals Inc. stock go up soonWeekly Market Summary & Reliable Intraday Trade Alerts - Newser
Will TNF Pharmaceuticals Inc. stock recover after recent dropWeekly Investment Summary & Community Consensus Stock Picks - Newser
Analyzing recovery setups for TNF Pharmaceuticals Inc. investorsJuly 2025 Recap & Technical Pattern Based Buy Signals - Newser
Can technical indicators confirm TNF Pharmaceuticals Inc.’s reversal2025 Breakouts & Breakdowns & Free Expert Verified Stock Movement Alerts - Newser
Chartists See Breakout Potential in TNF Pharmaceuticals Inc.2025 Volatility Report & Smart Money Movement Tracker - thegnnews.com
TNF Pharmaceuticals Enhances Financial Position with Major Liability Reduction - SSBCrack
How to track smart money flows in TNF Pharmaceuticals Inc.Earnings Recap Report & Technical Confirmation Trade Alerts - Newser
TNF Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
TNF Pharmaceuticals Enhances Financial Stability for Growth and Value Enhancement - AInvest
TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation - Business Wire
Earnings visualization tools for TNF Pharmaceuticals Inc.July 2025 Volume & AI Driven Stock Reports - Newser
Does TNF Pharmaceuticals Inc. show high probability of rebound2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Trend analysis for TNF Pharmaceuticals Inc. this weekForecast Cut & AI Forecast Swing Trade Picks - Newser
Key metrics from TNF Pharmaceuticals Inc.’s quarterly dataMarket Trend Review & Smart Swing Trading Alerts - Newser
Heatmap analysis for TNF Pharmaceuticals Inc. and competitors2025 Winners & Losers & Long-Term Growth Plans - Newser
Long term hold vs stop loss in TNF Pharmaceuticals Inc.2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Can TNF Pharmaceuticals Inc. rally from current levelsChart Signals & Smart Money Movement Tracker - Newser
Signal strength of TNF Pharmaceuticals Inc. stock in tech scannersTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Automated trading signals detected on TNF Pharmaceuticals Inc.Weekly Trade Report & Long-Term Safe Return Strategies - Newser
Is TNF Pharmaceuticals Inc. affected by consumer sentimentEarnings Beat & Low Drawdown Trading Strategies - newsyoung.net
Chart overlay techniques for tracking Coeptis Therapeutics Holdings Inc. Equity WarrantEarnings Risk Report & Safe Swing Trade Setup Alerts - Newser
Will TNF Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsMarket Weekly Review & Precise Swing Trade Alerts - Newser
TNF Pharmaceuticals TNFA 2025Q2 Earnings Preview Upside Potential on TNF-Alpha Advancements - AInvest
TNF Pharmaceuticals Delays 10-Q Filing - TipRanks
Detecting price anomalies in TNF Pharmaceuticals Inc. with AIWeekly Trend Report & Community Trade Idea Sharing Platform - Newser
What makes TNF Pharmaceuticals Inc. stock price move sharplyShare Buyback & Accurate Entry and Exit Point Alerts - Newser
TNF Pharmaceuticals Inc. stock chart pattern explainedQuarterly Portfolio Report & Long-Term Capital Growth Strategies - Newser
Tnf Pharmaceuticals Inc Stock (TNFA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.55%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):